Antimicrobial Resistance Profile by Metagenomic and Metatranscriptomic Approach in Clinical Practice: Opportunity and Challenge.

Waskito LA, Rezkitha YAA, Vilaichone RK, Wibawa IDN, Mustika S, Sugihartono T, Miftahussurur M

Open source

DOI
10.3390/antibiotics11050654
Published
2022 May 13
Container
Antibiotics (Basel, Switzerland)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/antibiotics11050654,
  title = {Antimicrobial Resistance Profile by Metagenomic and Metatranscriptomic Approach in Clinical Practice: Opportunity and Challenge.},
  author = {Waskito LA and Rezkitha YAA and Vilaichone RK and Wibawa IDN and Mustika S and Sugihartono T and Miftahussurur M},
  year = {2022},
  journal = {Antibiotics (Basel, Switzerland)},
  doi = {10.3390/antibiotics11050654},
  url = {https://doi.org/10.3390/antibiotics11050654}
}

RIS

TY  - JOUR
TI  - Antimicrobial Resistance Profile by Metagenomic and Metatranscriptomic Approach in Clinical Practice: Opportunity and Challenge.
AU  - Waskito LA
AU  - Rezkitha YAA
AU  - Vilaichone RK
AU  - Wibawa IDN
AU  - Mustika S
AU  - Sugihartono T
AU  - Miftahussurur M
PY  - 2022
JO  - Antibiotics (Basel, Switzerland)
DO  - 10.3390/antibiotics11050654
UR  - https://doi.org/10.3390/antibiotics11050654
ER  - 

APA

LA, W., YAA, R., RK, V., IDN, W., S, M., T, S., & M, M. (2022). Antimicrobial Resistance Profile by Metagenomic and Metatranscriptomic Approach in Clinical Practice: Opportunity and Challenge.. Antibiotics (Basel, Switzerland). https://doi.org/10.3390/antibiotics11050654

Source records